Skip to main content
Guardant Health, Inc. logo

Guardant Health, Inc. — Investor Relations & Filings

Ticker · GH ISIN · US40131M1099 LEI · 254900M8C3E5VC8BR186 US Human health and social work activities
Filings indexed 1,058 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US GH

About Guardant Health, Inc.

https://guardanthealth.com/

Guardant Health is a precision oncology company focused on transforming cancer care through its proprietary blood-based diagnostics. The company specializes in liquid biopsy technology, providing comprehensive genomic profiling (CGP) for patients with solid tumors. Its tests analyze circulating tumor DNA (ctDNA) from a simple blood draw to identify genomic alterations that can guide personalized treatment decisions. Guardant Health's portfolio addresses the full continuum of cancer care, including therapy selection for advanced cancer, recurrence monitoring, and early-stage cancer detection. By leveraging data and non-invasive technology, the company aims to improve clinical outcomes for patients at all stages of the disease.

Recent filings

Filing Released Lang Actions
10-Q - Guardant Health, Inc. (0001576280) (Filer)
Interim / Quarterly Report
2026-05-07 English
DEF 14A - Guardant Health, Inc. (0001576280) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English
8-K - Guardant Health, Inc. (0001576280) (Filer)
Regulatory Filings
2026-04-27 English
SCHEDULE 13G/A - Guardant Health, Inc. (0001576280) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - Guardant Health, Inc. (0001576280) (Issuer)
Director's Dealing
2026-03-23 English
4 - Guardant Health, Inc. (0001576280) (Issuer)
Director's Dealing
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.